Efficacy of Ipack Block and Surgeon's Joint Infiltration in Total Knee Arthroplasty

Completed · Phase 4

Conditions studied: Osteo Arthritis Knee

In brief

Total knee arthroplasty(TKA) is an effective modality for the treatment of advanced osteoarthritis of the knee joint with excellent outcomes. With 719,000 cases being performed as of 2010, the incidence is expected to increase up to 3.48 million procedures annually by 2030.

Key facts

Study ID

NCT03653416

Run by

Icahn School of Medicine at Mount Sinai

People needed

99

Starts

2018-03-01

Expected to finish

2019-08-01

Last updated by the study team

2020-11-03

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• ASA (American Society of Anesthesiology) class I-IV
• age 18-75.

You may not qualify if…

• ASA class V
• morbid obesity
• patient refusal
• patients with chronic pain or on pain medication
• allergy to LA
• patients receiving any additional regional techniques
• coagulopathy
• patients receiving systemic anticoagulation
• local infection and procedures anticipated to last more than 5 hours.

Where it is running

• Icahn School of Medicine at Mount Sinai — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.